DBV Technologies (DBVT) Cash from Investing Activities (QoQ) (2020 - 2026)
DBV Technologies (DBVT) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | DBV Technologies | 6.06 Bn | 5.88 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -100.00% |
| Mar 31, 2026 | 58.04% |
| Dec 31, 2025 | -181.50% |
| Mar 31, 2025 | -150.44% |
| Dec 31, 2024 | 827.52% |
| Sep 30, 2024 | -115.77% |
| Jun 30, 2024 | 132.41% |
| Mar 31, 2024 | -1,040.11% |
| Dec 31, 2023 | 41.93% |
| Sep 30, 2023 | 5.57% |
| Jun 30, 2023 | -911.90% |
| Mar 31, 2023 | 223.53% |
| Dec 31, 2022 | -122.37% |
| Sep 30, 2022 | 166.38% |
| Jun 30, 2022 | -2,181.82% |
| Mar 31, 2022 | 102.32% |
| Dec 31, 2021 | -977.78% |
| Sep 30, 2021 | -68.60% |
| Jun 30, 2021 | 192.97% |
| Mar 31, 2021 | 70.77% |